Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | LTA4H | P09960 | 6/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.38 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.38 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21630305 | 0.85 | TEAD4 (0.44) | ARALDH1A1SMN1; SMN2MEN1KMT2A | |
| SCHEMBL21630390 | 0.85 | LTA4H (0.41) | MAOAMAOBLTA4HALDH1A1SMN1; SMN2 | |
| SCHEMBL21630310 | 0.85 | MAPT (0.44) | MAOAMAOBLTA4HALDH1A1MAPT | |
| SCHEMBL21630308 | 0.85 | SOS1 (0.38) | PDE4APDE4BPDE4CPDE4DSCN9A | |
| SCHEMBL4156310 | 0.84 | LTA4H (0.48) | MAOAMAOBLTA4HALDH1A1SMN1; SMN2 | |
| SCHEMBL28575004 | 0.81 | S1PR2 (0.34) | LTA4HSMN1; SMN2LMNASCN9A | |
| SCHEMBL21630309 | 0.81 | MAOA (0.44) | MAOAMAOBLTA4HARALDH1A1 | |
| SCHEMBL921457 | 0.81 | MAOA (0.44) | MAOAMAOBLTA4HARALDH1A1 | |
| SCHEMBL21632255 | 0.80 | HAO1 (0.33) | — | |
| SCHEMBL21630319 | 0.80 | PARP15 (0.42) | MAOBARALDH1A1SMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113717035-B | Recycling method of difenoconazole waste intermediate | 江苏禾本生化有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-114437049-A | Preparation method for synthesizing difenoconazole by three-step method | 江西农业大学 | 2022-05-06 | — | — | CN | claimed |
| CN-113717035-A | Recycling method of difenoconazole waste intermediate | 江苏禾本生化有限公司 | 2021-11-30 | — | — | CN | claimed |
| EP-1465869-B1 | MODULATORS OF LXR | EXELIXIS PATENT CO LLC (US) | 2013-05-15 | — | — | EP | claimed |
| CN-102432566-A | 2- (4-phenoxyphenyl) oxirane and preparation method and application thereof | UNIV HUNAN | 2012-05-02 | — | — | CN | claimed |
| US-7998986-B2 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | claimed |
| US-6989351-B2 | Metabolic inhibitors against brassinosteroids | RIKEN (JP) | 2006-01-24 | — | — | US | claimed |
| EP-1465869-A4 | MODULATORS OF LXR | X CEPTOR THERAPEUTICS INC (US) | 2005-12-28 | — | — | EP | claimed |
| JP-2005536450-A | — | — | 2005-12-02 | — | — | JP | claimed |
| US-20040259735-A1 | Metabolic inhibitors against brassinosteroids | RIKEN (JP) | 2004-12-23 | — | — | US | claimed |
| EP-1465869-A1 | MODULATORS OF LXR | X-Ceptor Therapeutics, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS, INC. | 2003-09-25 | — | — | US | claimed |
| WO-2003059884-A1 | MODULATORS OF LXR | X-CEPTOR THERAPEUTICS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| EP-1304038-A1 | METABOLIC INHIBITORS AGAINST BRASSINOSTEROIDS | RIKEN (JP) | 2003-04-23 | — | — | EP | claimed |
| EP-0572085-A1 | Fungicidal compositions | ISAGRO S.r.l. (IT) | 1993-12-01 | — | — | EP | claimed |
| CN-113717035-B | Recycling method of difenoconazole waste intermediate | 江苏禾本生化有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-113717035-B | Recycling method of difenoconazole waste intermediate | 江苏禾本生化有限公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-0529974-A1 | Fungicidal 2-aryl-2-cyano-2-(aryloxyalkyl)ethyl-1,2,4-triazoles | ROHM AND HAAS COMPANY (US) | 1993-03-03 | — | — | EP | disclosed |
| US-5162329-A | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1992-11-10 | — | — | US | disclosed |
| EP-0461487-A2 | Beta picoline derivatives and plant protecting agents containing them | BASF Aktiengesellschaft (DE) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | NR1H2, NR1H3, NCOA1 | MAOA 1629/4885MAOB 1238/4885LTA4H 1706/4885 |
| US-20040259735-A1 | Metabolic inhibitors against brassinosteroids | DBI, HSD17B4, ABHD5 | MAOA 3498/4885MAOB 2370/4885LTA4H 2774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.